Lamitor 25 mg, 50 mg , 100 mg, 200 mg Tablets
PDF Leaflet Revision Date: 12 December 2008
Clinical Summary
Quick overview from the medicine insert
Indication
Monotherapy or add-on treatment for partial and primary generalized tonic-clonic seizures.
Dosage (summary)
Adults: Start 25 mg daily, increase to 100-200 mg/day. Children: 0.6 mg/kg daily, max 400 mg.
Onset of Action / Duration
Onset: 1.4 to 4.8 hours, Duration: 25 u00b1 10 hours
Special Populations
- Renal impairment
- Hepatic impairment
- Elderly patients
Pregnancy & Breastfeeding
Safety in pregnancy and lactation not established.
Key Drug Interactions
- Enzyme inducers (e.g., phenytoin, carbamazepine)
- Valproic acid
Contraindications
- Hypersensitivity to lamotrigine
- Pregnancy
- Renal and hepatic impairment
- Patients over 65 years
Common side effects
- Skin rash
- Headache
- Nausea
- Dizziness
Counselling Points
- Report any rash or flu-like symptoms immediately
- Monitor weight in children
- Do not exceed recommended dosages
Serious warnings
- Risk of severe skin reactions
- Monitor for hypersensitivity symptoms
- Abrupt withdrawal may provoke seizures
Important Disclaimer
The Lamitor 25 mg, 50 mg , 100 mg, 200 mg Tablets professional information leaflet below is the property of Dr Reddy’S Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
